HK Stock Market Move | HAICHANG HLDG(02255) rose more than 20% in early trading. On the first day of Shanghai HAICHANG HLDG New Year holiday, visitor traffic increased by 60% year-on-year.
Chimelong Ocean Kingdom (02255) rose more than 20% in the morning session. As of the time of this report, it increased by 14.29%, to 0.56 Hong Kong dollars, with a trading volume of 79.8891 million Hong Kong dollars.
HAICHANG HLDG(02255) rose more than 20% in early trading, as of the time of writing, it rose 14.29% and is trading at 0.56 Hong Kong dollars, with a turnover of 79.8891 million Hong Kong dollars.
On the news front, according to reports from ThePaper, on January 4, HAICHANG HLDG disclosed data showing that during the New Year holiday, foot traffic at Shanghai HAICHANG HLDG on the first day of the holiday increased by 60% year-on-year, with three theme hotels fully booked for three consecutive days. The number of guests received at Zhengzhou HAICHANG HLDG on New Year's Eve and the first day of the holiday increased by nearly 120% compared to the same period last year. Ocean-themed hotels and Ultraman-themed hotels were particularly popular, with many unique theme rooms selling out early, leading to a peak in "rooms are hard to come by" bookings.
Related Articles

VIRTUAL MIND (01520) plans to invest in Huarui Entertainment through capital increase to further expand the sports smart new consumption business.

Zhejiang Extek Technology (301399.SZ) plans to establish a subsidiary in Hangzhou with a capital of 30 million yuan.

HK Stock Market Move | RIBOLIFE-B(06938) morning surged more than 3%, the company's pipeline has FIC potential, already leading into phase 2 clinical trials.
VIRTUAL MIND (01520) plans to invest in Huarui Entertainment through capital increase to further expand the sports smart new consumption business.

Zhejiang Extek Technology (301399.SZ) plans to establish a subsidiary in Hangzhou with a capital of 30 million yuan.

HK Stock Market Move | RIBOLIFE-B(06938) morning surged more than 3%, the company's pipeline has FIC potential, already leading into phase 2 clinical trials.






